Medicine for treating nasosinusitis

A technology for sinusitis and drugs, applied in the field of drugs for treating sinusitis, can solve the problems of not getting better, dry nasal cavity, accompanying bleeding, etc., and achieve the effect of improving immunity of the body and treating sinusitis

Inactive Publication Date: 2008-05-28
李会敏
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are many Chinese patent medicines for treating sinusitis in the market, such as Biyuanshu Oral Liquid, Biyan Pills, Biyankang Tablets, etc., but these medicines are not effective. Aggravated, the nasal cavity is very dry and accompanied by bleeding, the condition has not improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] The capsule preparation of embodiment 1 medicine of the present invention

[0018] Take 30g of raw gypsum, 12g of cocklebur, 15g of Angelica dahurica, 10g of Magnolia magnolia, 10g of mint, 15g of goose and herbaceous herbs, add water and decoct twice, each time adding six times the amount of water, combine the two decoctions, filter to obtain the filtrate, Concentrate into extract, add 90%-95% ethanol for alcohol precipitation, recover ethanol and concentrate, dry to obtain dry extract, then crush it into fine powder, and pack into hard gelatin capsules.

Embodiment 2

[0020] Treatment of patients with sinusitis

[0021] 1. General Information

[0022] A total of 30 outpatients were admitted, including 15 males and 15 females. Nine cases were aged 10-19 years, 7 cases were 20-30 years old, 8 cases were 31-40 years old, 5 cases were 41-50 years old, and 1 case was over 50 years old.

[0023] 2. Diagnostic criteria

[0024] (1) TCM diagnostic criteria

[0025] 1. Lung meridian wind-heat type: symptoms include nasal congestion, yellow or sticky mucus, profuse, headache, sore throat, reddish tongue, thin white or yellowish fur, floating and rapid pulse.

[0026] 2. Gallbladder stagnant heat type: Syndrome of nasal congestion, yellow and sticky mucus, foul smell, poor sense of smell, headache and severe pain in the affected area, fever, bitter mouth and dry throat, irritability, red tongue, yellow fur, stringy pulse number.

[0027] 3. Damp-heat type of spleen meridian: yellow and profuse nasal mucus, severe and persistent nasal congestion, ...

Embodiment 3

[0042] The capsule preparation of embodiment 3 medicines of the present invention

[0043] Take 30g of raw gypsum, 12g of cocklebur, 15g of Angelica dahurica, 10g of magnolia, 10g of mint, 15g of goose herb, 6g of asarum, 20g of pine pollen, 10g of chrysanthemum, and 10g of gentian. The amount of water added is six times the amount, the two decoctions are combined, the filtrate is filtered, concentrated into an extract, and 90%-95% ethanol is added for alcohol precipitation, the ethanol is recovered and concentrated, and dried to obtain a dry extract, which is then pulverized Into fine powder, into gelatin hard capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine used for treating nasosinusitis, which is mainly prepared by gypsum, siberian cocklebur fruit, angelica, biond magnolia flower, peppermint, and small centipeda herb according to a certain weight proportion, and can be prepared into any kind of common oral preparation. The invention has the efficacies of reducing fever, apocenosis, relieving exterior syndrome and clearing the interior, recanalizing orifices, promoting diuresis and improving organic immunity; nasosinusitis can be effectively cured.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a medicine for treating sinusitis. Background technique [0002] Sinusitis is a common disease, often caused by protracted cold. Generally speaking, sinusitis refers to the chronic inflammation of the maxillary sinus. This is because the volume of the maxillary sinus is the largest, and the position of the sinus ostium is higher than that of the sinus floor. Therefore, once inflammatory secretions appear, it is difficult to discharge. Clinically, it is mainly manifested by polypus nasal discharge, accompanied by nasal congestion and headache, which not only affects the normal work and life of the patient, but also reduces the patient's intelligence level. [0003] At present, there are two kinds of clinical treatment of sinusitis: surgical treatment and drug treatment. Surgical treatment refers to pumping out the pus in the sinuses through puncture, and then injecti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/575A61P11/02A61K33/06
Inventor 李会敏
Owner 李会敏
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap